Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study-Reference-Cited by-同舟云学术

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

Published:2011-05 Issue:5 Volume:105 Page:719-726
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Korn Stephanie,Kerwin Edward,Atis Sibel,Amos Carolynn,Owen Roger,Lassen Cheryl

Funder

Novartis Pharma AG

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. Global burden of COPD: systematic review and meta-analysis;Halbert;Eur Respir J,2006

2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease;Global initiative for chronic obstructive lung disease (GOLD),2009

3. Contemporary management of chronic obstructive pulmonary disease: scientific review;Sin;JAMA,2003

4. The role of long-acting bronchodilators in the management of stable COPD;Tashkin;Chest,2004

5. Patient adherence in COPD;Bourbeau;Thorax,2008

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma;Current Respiratory Medicine Reviews;2022-05

2. Experience with the triple fixed combination in patients with chronic obstructive pulmonary disease;Meditsinskiy sovet = Medical Council;2022-01-06

3. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease;Clinics in Chest Medicine;2020-09

4. Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration;Pulmonary Pharmacology & Therapeutics;2020-04

5. Pharmacotherapy for chronic obstructive pulmonary disease;Journal of the Korean Medical Association;2019